The neurobiological foundation of bipolar disorder involves disrupted signaling across multiple brain circuits. Research shows that individuals with bipolar disorder have altered glutamate and GABA neurotransmitter levels, with glutamate — the brain’s primary excitatory neurotransmitter — playing a central role in the rapid mood cycling that defines the condition. Functional imaging studies reveal that prefrontal cortex activity can decrease by up to 25% during depressive episodes.
During depressive phases, reduced synaptic connectivity and diminished neuroplasticity impair the brain’s ability to regulate emotion and maintain stable mood states. The resulting imbalance between excitatory and inhibitory neural circuits creates the characteristic pendulum swing between depression and mania that patients experience.
Genetic vulnerability accounts for approximately 60-80% of bipolar disorder risk, but environmental stressors — including sleep disruption, major life changes, and substance use — often trigger initial episodes. This interplay between inherited predisposition and environmental factors explains why bipolar disorder typically emerges in late adolescence or early adulthood, when both biological and psychosocial stressors converge.
